Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myrcene + linalool is a combination of two naturally occurring terpenes, commonly found in cannabis and other plants. Myrcene is a monoterpene known for its earthy, musky aroma and is associated with sedative, muscle-relaxing, analgesic, and anti-inflammatory effects. Linalool is a monoterpenoid with a floral scent, noted for calming, anxiolytic, and mildly sedative properties. When combined, these terpenes exhibit a synergistic effect, often resulting in enhanced relaxation, sedation, muscle relaxation, and potential sleep-inducing benefits, commonly referred to as the "entourage effect" in cannabis science. This combination is primarily used in the context of aromatherapy, dietary supplements, and cannabis formulations intended for stress relief, anxiety reduction, and sleep support[1][4][7][8]. The mechanism of action involves modulation of GABAergic and possibly opioid receptor activity in the central nervous system, influencing neurotransmission to promote relaxation, reduce anxiety, and provide mild analgesia[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myrcene + linalool.